Avacta Group (Avacta Group) ROE % Adjusted to Book Value : -7.45% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Avacta Group ROE % Adjusted to Book Value?

Avacta Group's ROE % for the quarter that ended in Dec. 2023 was -120.62%. Avacta Group's PB Ratio for the quarter that ended in Dec. 2023 was 16.20. Avacta Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -7.45%.

Avacta Group ROE % Adjusted to Book Value Historical Data

The historical data trend for Avacta Group's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avacta Group ROE % Adjusted to Book Value Chart

Avacta Group Annual Data

Trend

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-10.34

-7.06

-6.57

-7.87

Avacta Group Semi-Annual Data
	Jul13	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-9.20	-8.90	-12.12	-7.82	-7.45

Competitive Comparison of Avacta Group's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Avacta Group's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avacta Group's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avacta Group's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Avacta Group's ROE % Adjusted to Book Value falls into.

Avacta Group ROE % Adjusted to Book Value Calculation

Avacta Group's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-126.16%	/	16.04
	=	-7.87%

Avacta Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-120.62%	/	16.20
	=	-7.45%

Avacta Group ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Avacta Group's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Avacta Group (Avacta Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avacta Group PLC (OTCPK:AVCTF) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

AVCT:UK RTQ1:Germany

Address

Unit 20, Ash Way, Thorp Arch Estate, West Yorkshire, Wetherby, GBR, LS23 7FA

Website

https://www.avacta.com

Avacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The company is developing novel cancer immunotherapies combining its two proprietary platforms Affimer biotherapeutics and precision tumor-targeted chemotherapy. The company operates in the United Kingdom, France, South Korea, Rest of Europe, Asia, and North America.